Skip to content
Catalyst

psilocybinPapers

Papers about psilocybin

papers
210
25 years, by papers

Newest first

101 to 150 of 210

Every paper here, unless its row says otherwiseIndexed under psilocybin in PubMed's chemical list; returned by a PubMed search for psilocybin

  • A retrospective study of the characteristics and toxicology of cases of lysergic acid diethylamide (LSD)- and psilocybin-related death in Australia.

    Addiction (Abingdon, England)2024PMID 38771189Also indexed under psilocybin as a PubMed major topic

  • The effects of psilocybin on cognition and emotional processing in healthy adults and adults with depression: a systematic literature review.

    Journal of clinical and experimental neuropsychology2024PMID 38842300Also indexed under psilocybin as a PubMed major topic

  • Protocols and practices in psilocybin assisted psychotherapy for depression: A systematic review.

    Journal of psychiatric research2024PMID 38850581Also indexed under psilocybin as a PubMed major topic

  • Psilocybin and 2C-B at Encoding Distort Episodic Familiarity.

    Biological psychiatry2024PMID 38942147Also indexed under psilocybin as a PubMed major topic

  • Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy.

    Scientific reports2024PMID 39019922Also indexed under psilocybin as a PubMed major topic

  • Altered states of consciousness in Danish healthy volunteers and recreational users of psilocybin and the possible impact of setting and intention: Danish validation of the five-dimensional altered states of consciousness questionnaire.

    Journal of psychopharmacology (Oxford, England)2024PMID 39135498Also indexed under psilocybin as a PubMed major topic

  • Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis.

    BMJ (Clinical research ed.)2024PMID 39168500Compares against psilocybin; indexed under psilocybin in PubMed

  • Impact of psilocybin on cognitive function: A systematic review.

    Psychiatry and clinical neurosciences2024PMID 39354706Also indexed under psilocybin as a PubMed major topic

  • The impact of antidepressant discontinuation prior to treatment with psilocybin for treatment-resistant depression.

    Journal of psychiatric research2024PMID 39427449Also indexed under psilocybin as a PubMed major topic

  • Psilocybin-assisted neurofeedback for the improvement of executive functions: a randomized semi-naturalistic-lab feasibility study.

    Philosophical transactions of the Royal Society of London2024PMID 39428872Also indexed under psilocybin as a PubMed major topic

  • Enhanced visual contrast suppression during peak psilocybin effects: Psychophysical results from a pilot randomized controlled trial.

    Journal of vision2024PMID 39499526Also indexed under psilocybin as a PubMed major topic

  • Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic: A Randomized Clinical Trial.

    JAMA network open2024PMID 39636638Also indexed under psilocybin as a PubMed major topic

  • The Use of Psilocybin in the Treatment of Psychiatric Disorders with Attention to Relative Safety Profile: A Systematic Review.

    Journal of psychoactive drugs2023PMID 35225726

  • A systematic literature review and meta-analysis of the effect of psilocybin and methylenedioxymethamphetamine on mental, behavioural or developmental disorders.

    The Australian and New Zealand journal of psychiatry2023PMID 35285280

  • Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.

    Journal of affective disorders2023PMID 36740140Also indexed under psilocybin as a PubMed major topic

  • Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial.

    Journal of psychopharmacology (Oxford, England)2023PMID 36938991

  • How does psilocybin therapy work? An exploration of experiential avoidance as a putative mechanism of change.

    Journal of affective disorders2023PMID 37146908Also indexed under psilocybin as a PubMed major topic

  • Neurobiological Correlates of Psilocybin Response in Depression.

    The primary care companion for CNS disorders2023PMID 37230065Also indexed under psilocybin as a PubMed major topic

  • Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.

    Neuropsychopharmacology2023PMID 37231080Also indexed under psilocybin as a PubMed major topic

  • Assessment of the Acute Effects of 2C-B vs. Psilocybin on Subjective Experience, Mood, and Cognition.

    Clinical pharmacology and therapeutics2023PMID 37253161Also indexed under psilocybin as a PubMed major topic

  • Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use.

    Journal of psychopharmacology (Oxford, England)2023PMID 37291890

  • Psilocybin intoxication did not affect daytime or sleep-related declarative memory consolidation in a small sample exploratory analysis.

    European neuropsychopharmacology2023PMID 37336163

  • Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms.

    Journal of psychopharmacology (Oxford, England)2023PMID 37392016

  • Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis.

    Psychiatry research2023PMID 37523886Also indexed under psilocybin as a PubMed major topic

  • Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies.

    European neuropsychopharmacology2023PMID 37557019

  • Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences.

    Scientific reports2023PMID 37608057

  • Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study.

    Brain, behavior, and immunity2023PMID 37689275Also indexed under psilocybin as a PubMed major topic

  • Functional imaging studies of acute administration of classic psychedelics, ketamine, and MDMA: Methodological limitations and convergent results.

    Neuroscience and biobehavioral reviews2023PMID 37802267Indexed under psilocybin in PubMed's chemical list

  • Psilocybin-assisted therapy for depression: A systematic review and meta-analysis.

    Psychiatry research2023PMID 37844352

  • Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent rats.

    Translational psychiatry2023PMID 38097569

  • Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals.

    Journal of psychopharmacology (Oxford, England)2022PMID 34189985

  • Dose effect of psilocybin on primary and secondary depression: a preliminary systematic review and meta-analysis.

    Journal of affective disorders2022PMID 34587546Also indexed under psilocybin as a PubMed major topic

  • Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects.

    Clinical pharmacology and therapeutics2022PMID 34743319Indexed under psilocybin in PubMed's chemical list

  • Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study.

    Journal of psychopharmacology (Oxford, England)2022PMID 34915762

  • Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes.

    Journal of psychopharmacology (Oxford, England)2022PMID 34983261

  • The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.

    Journal of psychopharmacology (Oxford, England)2022PMID 35090363

  • Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.

    Journal of psychopharmacology (Oxford, England)2022PMID 35166158

  • Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects.

    Neuropsychopharmacology2022PMID 35217796

  • The therapeutic potential of psilocybin: a systematic review.

    Expert opinion on drug safety2022PMID 35225143

  • Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review.

    Psychopharmacology2022PMID 35253070

  • Increased global integration in the brain after psilocybin therapy for depression.

    Nature medicine2022PMID 35411074

  • Don't be afraid, try to meditate- potential effects on neural activity and connectivity of psilocybin-assisted mindfulness-based intervention for social anxiety disorder: A systematic review.

    Neuroscience and biobehavioral reviews2022PMID 35679988

  • Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study.

    Translational psychiatry2022PMID 35918311

  • A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review.

    CNS drugs2022PMID 36097251Also indexed under psilocybin as a PubMed major topic

  • Esketamine and Psilocybin-The Comparison of Two Mind-Altering Agents in Depression Treatment: Systematic Review.

    International journal of molecular sciences2022PMID 36232748

  • Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.

    The New England journal of medicine2022PMID 36322843Also indexed under psilocybin as a PubMed major topic

  • Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial.

    Headache2022PMID 36416492

  • "A sense of the bigger picture:" A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use.

    PloS one2022PMID 36516137

  • Efficacy of Psychoactive Drugs for the Treatment of Posttraumatic Stress Disorder: A Systematic Review of MDMA, Ketamine, LSD and Psilocybin.

    Journal of psychoactive drugs2021PMID 32931403

  • Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.

    JAMA psychiatry2021PMID 33146667

The next 50 papers

← Previous 50